Andrew Fromkin
DirectoratImmunovant· In proxies 2023–2025
Andrew Fromkin sits on 2 public boards.
Experience
- ImmunovantPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +410%
- Regado Biosciences, Inc.Public company
- Director? – PresentNo stock prices for these years
- Tobira Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?